Article Text

Download PDFPDF

Chronic disease
P2-331 Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review
  1. J C Wilson,
  2. L Anderson,
  3. L Murray,
  4. C Hughes
  1. Queen's University Belfast, Belfast, UK


Introduction Use of non-steroidal anti-inflammatory drugs (NSAIDs) has been associated with a reduced risk of several cancers. We conducted a systematic literature review to investigate the association between NSAID/aspirin use and risk of head and neck cancer (HNC).

Method Medline, Embase, PubMed, Cochrane Library and Web of Science were systematically searched using terms for NSAIDs/aspirin, HNC and observational/intervention study designs.

Results Of 9268 articles identified, two population-based prescribing database studies and three case-control studies met the selection criteria. The studies investigated different HNC sites. Only one study found a significant protective effect of aspirin use for HNC risk (OR 0.75, 95% CI 0.58 to 0.96) and one showed a significantly increased risk of oral/oropharangeal cancer with non-low-dose aspirin NSAID use (OR 3.5, 95% CI 1.8 to 6.7).

Conclusion No definitive conclusion on the effect of NSAIDs/aspirin on HNC risk was possible. Further robust large-scale studies are required to clarify any possible association.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.